IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 158 filers reported holding IMMUNOGEN INC in Q4 2016. The put-call ratio across all filers is 5.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | -50.0% | 1,257 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $6,000 | 0.0% | 1,257 | +11.2% | 0.00% | 0.0% |
| Q3 2018 | $6,000 | -45.5% | 1,130 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $11,000 | -8.3% | 1,130 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | -14.3% | 1,130 | -49.3% | 0.00% | -20.0% |
| Q4 2017 | $14,000 | -58.8% | 2,230 | -49.0% | 0.01% | -61.5% |
| Q3 2017 | $34,000 | +9.7% | 4,370 | -0.5% | 0.01% | 0.0% |
| Q2 2017 | $31,000 | +72.2% | 4,391 | -3.1% | 0.01% | +62.5% |
| Q1 2017 | $18,000 | +80.0% | 4,530 | -3.6% | 0.01% | +60.0% |
| Q4 2016 | $10,000 | -16.7% | 4,700 | +4.1% | 0.01% | -16.7% |
| Q3 2016 | $12,000 | -20.0% | 4,513 | -2.1% | 0.01% | -14.3% |
| Q2 2016 | $15,000 | -61.5% | 4,612 | 0.0% | 0.01% | -63.2% |
| Q1 2016 | $39,000 | -32.8% | 4,612 | +7.2% | 0.02% | -26.9% |
| Q4 2015 | $58,000 | – | 4,304 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |